CliffBio
small molecule

METHOCARBAMOL

METHOCARBAMOL

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETHOCARBAMOL
Active ingredientMETHOCARBAMOL
Strength1GM/10ML (100MG/ML)
Dosage formSOLUTION
RouteIM-IV
ModalitySmall molecule
FDA approvalApril 2018
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.